SeaBeLife Biotech

Description

SeaBeLife is pioneering a first-in-class approach to preventing organ failure by targeting dual inhibition of necroptosis and ferroptosis, pathways involved in severe liver and retinal diseases. Currently, we are advancing two assets through preclinical development: SBL01, designed to address life-threatening orphan and acute liver diseases, and SBL03, aiming to preserve vision in Dry-AMD patients, a leading cause of blindness globally among the elderly. These initiatives promise to transform patient outcomes, addressing significant social, economic, and healthcare challenges.

Company members

Morgane Rousselot

HealthTech Innovation Days - 6th edition is an event organized by HealthTech For Care.

HealthTech For Care is an endowment fund (non-for profit organization) whose primary mission is to advocate for universal access to healthcare for all European patients, with a specific focus on advanced medical technologies and innovative drugs. The fund's initiatives and events with a European dimension gather all stakeholders involved in the health innovation value chain, fostering better coordination within the European health ecosystem. HealthTech For Care is administered by a board of European experts.

For any request: contact@htfc-eu.com
Where to find us? Healthtech For Care, 10 Place de Catalogne, 75014 Paris

SeaBeLife Biotech

Description

Company members

© HealthTech For Care 2022-2024 - All rights reserved

Cookies Policy

Legal notice

Privacy Policy